TITUS A TAUBE

Allopathic & Osteopathic Physicians|Family Medicine WARNER ROBINS, GA NPI 1891752804

General Payments — all program years on this page

$4,037.47

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 245
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $298.80 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $298.8016

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $747.4343
2019 $628.9844
2020 $742.2853
2021 $710.6442
2022 $488.0026
2023 $421.3421
2024 $298.8016

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086212129 Bayer Healthcare Pharmaceuticals Inc. $16.14 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086229346 Bayer Healthcare Pharmaceuticals Inc. $18.53 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086239464 Bayer Healthcare Pharmaceuticals Inc. $17.53 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086242508 Bayer Healthcare Pharmaceuticals Inc. $22.58 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096587975 Novo Nordisk Inc $18.20 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096753688 Novo Nordisk Inc $17.28 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114928515 Exact Sciences Corporation $15.55 07/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116335917 GlaxoSmithKline, LLC. $21.58 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116454831 GlaxoSmithKline, LLC. $27.55 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117698130 Amgen Inc. $19.21 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117698132 Amgen Inc. $14.42 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117698134 Amgen Inc. $15.12 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117698136 Amgen Inc. $14.05 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118220313 Boehringer Ingelheim Pharmaceuticals, Inc. $13.71 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118220317 Boehringer Ingelheim Pharmaceuticals, Inc. $33.44 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125325056 Abbott Laboratories $13.91 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.